Cutaneous toxoplasmosis in an immunosuppressed dog

Oliveira, T.S.; Turchetti, A; Barbosa, Fabíola Brasil; Bicalho, A.L.F.; Alencar, Cid Aristóteles de Siqueira; Paixão, Tatiane Alves da; Santos, Renato L.

doi:10.1590/1678-41626891

Cited by 4 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In another case, disseminated toxoplasmosis involving acute respiratory distress syndrome and septic shock occurred in a cat (26) after the use of cyclosporine for eosinophilic dermatitis treatment. Several dogs developed cutaneous toxoplasmosis after treatment with prednisone and cyclosporine against immune-mediated thrombocytopenia and immune-mediated hemolytic anemia (14, 16, 17, 69). Moreover, topical anti-inflammatory therapy required to control keratoconjunctivitis sicca in a dog triggered a necrotizing conjunctivitis by T. gondii (11).…”

Section: Immunosupression and Clinical Toxoplasmosismentioning

confidence: 99%

Clinical Toxoplasmosis in Dogs and Cats: An Update

Calero‐Bernal

Gennari

2019

Front. Vet. Sci.

View full text Add to dashboard Cite

Toxoplasmosis is caused by the globally distributed protozoan parasite Toxoplasma gondii (phylum Apicomplexa); the disease can be clinically important for almost all homeothermic animals, including birds and humans. Toxoplasmosis course involves general clinical signs, such as fever, anorexia, or dyspnea, and more specific signs with neural, respiratory, cutaneous, or ocular involvement. Because of the wide range of clinical signs, the diagnosis in domestic and pet animals can be complicated. Hence, this review aims to provide a comprehensive analysis of some scarcely discussed aspects of toxoplasmosis, such as ocular and cutaneous manifestations, congenital infections, influence of T. gondii genotype on clinical toxoplasmosis, and recent findings regarding differential diagnosis. This review could be of special interest to clinicians and researchers.

show abstract